Compare Elder Pharma with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA ALEMBIC LTD ELDER PHARMA/
ALEMBIC LTD
 
P/E (TTM) x -0.2 64.3 - View Chart
P/BV x 0.1 2.3 4.4% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ELDER PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ALEMBIC LTD
Mar-18
ELDER PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs38072 527.8%   
Low Rs18834 554.6%   
Sales per share (Unadj.) Rs491.24.7 10,449.6%  
Earnings per share (Unadj.) Rs-3.26.1 -52.1%  
Cash flow per share (Unadj.) Rs14.46.2 230.7%  
Dividends per share (Unadj.) Rs00.20 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.540.7 926.0%  
Shares outstanding (eoy) m20.54267.03 7.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.611.3 5.1%   
Avg P/E ratio x-89.38.7 -1,029.0%  
P/CF ratio (eoy) x19.78.5 232.5%  
Price / Book Value ratio x0.81.3 57.9%  
Dividend payout %03.3 0.0%   
Avg Mkt Cap Rs m5,83314,139 41.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,179207 1,050.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,0891,255 803.8%  
Other income Rs m257370 69.3%   
Total revenues Rs m10,3461,625 636.5%   
Gross profit Rs m-792111 -712.8%  
Depreciation Rs m36138 955.8%   
Interest Rs m2,7562 162,135.3%   
Profit before tax Rs m-3,653442 -826.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m12524 522.5%   
Profit after tax Rs m-651,630 -4.0%  
Gross profit margin %-7.88.9 -88.7%  
Effective tax rate %-3.45.4 -63.2%   
Net profit margin %-0.6129.8 -0.5%  
BALANCE SHEET DATA
Current assets Rs m9,2401,867 494.9%   
Current liabilities Rs m9,998591 1,691.1%   
Net working cap to sales %-7.5101.6 -7.4%  
Current ratio x0.93.2 29.3%  
Inventory Days Days4694 49.1%  
Debtors Days Days6074 81.5%  
Net fixed assets Rs m10,1241,791 565.3%   
Share capital Rs m206534 38.5%   
"Free" reserves Rs m5,58210,324 54.1%   
Net worth Rs m7,73410,858 71.2%   
Long term debt Rs m4,88941 11,866.5%   
Total assets Rs m22,88211,591 197.4%  
Interest coverage x-0.3260.9 -0.1%   
Debt to equity ratio x0.60 16,660.4%  
Sales to assets ratio x0.40.1 407.1%   
Return on assets %11.814.1 83.5%  
Return on equity %-0.815.0 -5.6%  
Return on capital %22.315.2 146.9%  
Exports to sales %3.01.5 196.6%   
Imports to sales %0.421.0 2.0%   
Exports (fob) Rs m30719 1,580.4%   
Imports (cif) Rs m43263 16.4%   
Fx inflow Rs m30719 1,580.4%   
Fx outflow Rs m125264 47.5%   
Net fx Rs m181-244 -74.2%   
CASH FLOW
From Operations Rs m11,754236 4,984.8%  
From Investments Rs m-561-224 250.2%  
From Financial Activity Rs m-6,762-27 25,420.3%  
Net Cashflow Rs m4,432-15 -29,943.9%  

Share Holding

Indian Promoters % 39.6 64.0 61.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.2 3,750.0%  
FIIs % 16.8 9.7 173.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 26.1 138.3%  
Shareholders   16,479 54,701 30.1%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  AJANTA PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS